baber/WOPTO huggingface dataset:
Patent NZ-609324-A (NZ)
Title: Biomarker for alzheimer’s disease or mild cognitive impairment
Inventor: SATO YOSHIAKI
IPC: G01N33/15
Filed: 2011-06-23
Abstract: Disclosed is a method for evaluating an effect of a candidate for a therapeutic agent to treat Alzheimer’s disease or mild cognitive impairment, the method comprising: (i) a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in blood of a non-human animal; a step of administering a candidate to the non-human animal; a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in blood of the non-human animal after the candidate is administered; and a step of providing an indicator of being potential for the candidate to be effective in treating Alzheimer’s disease or mild cognitive impairment when the desmosterol level in blood of the non-human animal after the candidate is administered is higher than the level before the candidate is administered, or when the desmosterol level and the one or more additional biomarker level(s) in blood of the non-human animal after the candidate is administered are higher than those before the candidate; (ii) a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in blood of a first non-human animal; a step of administering a candidate to a second non-human animal; a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in blood of the second non-human animal after the candidate is administered; and a step of providing an indicator of being potential for the candidate to be effective in treating Alzheimer’s disease or mild cognitive impairment when the desmosterol level in blood of the second non-human animal after the candidate is administered is higher than the desmosterol level in blood of the first non-human animal to which the candidate is not administered, or when the desmosterol level and the one or more additional biomarker level(s) in blood of the second non-human animal after the candidate is administered are higher than those in blood of the first non-human animal to which the candidate is not administered; or (iii) a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in a blood sample of a subject before a candidate is administered; a step of measuring a desmosterol level and/or one or more additional biomarker level(s) in the blood sample of the subject after the candidate is administered; and a step of providing an indicator of being potential for the candidate to be effective in treating Alzheimer’s disease or mild cognitive impairment when the desmosterol level in the blood sample of the subject after the candidate is administered is higher than the desmosterol level in blood before the candidate is administered, or when the desmosterol level and the one or more additional biomarker level(s) in the blood sample of the subject after the candidate is administered are higher than those before the candidate is administered, wherein the additional biomarkers are selected from amyloid beta, gelsolin, or a combination thereof.
Patent NZ-611257-A (NZ)
Title: Device for weed control
Inventor: HOBBS RICHARD
IPC: A01M21/04
Filed: 2011-11-08
Abstract: Disclosed is an apparatus (10) suitable for controlling vegetation. The apparatus comprises a hot-liquid reservoir (28) containing water, release means (38) connected to the hot-liquid reservoir and at least one nozzle (74) connected to the reservoir via the release means. The apparatus includes a heating means (34) to heat the liquid in a plurality of stages in succession to a temperature above 102 degrees Celcius such that the pressure in the reservoir is above atmospheric pressure. In use, the liquid does not boil until it emerges from the nozzle, where it combines with a surfactant to for a foam that contains steam. This foam containing steam advantageously acts as a thermal blanket to further prolong heat exposure to the vegetation to be controlled. The apparatus is mounted on a vehicle or a vehicle drawn wheeled trolley or trailer. A method of controlling vegetation is also disclosed.
Patent NZ-618594-A (NZ)
Title: Hepatitis c virus inhibitors
Inventor: MEANWELL NICHOLAS A
IPC: C07K5/12
Filed: 2012-05-01
Abstract: Disclosed are macrocyclic peptide-based inhibitors of hepatitis C virus (HCV) compounds of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are: 1,1,1-trifluoro-2-methylpropan-2-yl (2R,6S,7R,9R,13aS,14aR,16aS,Z)- 14a-(cyclopropylsulfonylcarbamoyl)-7-ethyl-2-(4-methoxyisoquinolin-1-yloxy)-9-methyl-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16ahexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-ylcarbamate; tert-butyl ((2R,6S,7R,9S,13aS,14aR,16aS,Z)-7-ethyl-14a-(((1-(fluoromethyl)cyclopropyl)sulfonyl)carbamoyl)-2-((3-methoxyisoquinolin-1-yl)oxy)-9-methyl-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16ahexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl)carbamate and (2R,6S,7R,9R,13aR,14aR,16aS)-6-(3-(tert-butyl)ureido)-N-((1- (fluoromethyl)cyclopropyl)sulfonyl)-2-((4-methoxyisoquinolin-1-yl)oxy)-7,9-dimethyl-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide.
Patent NZ-618891-A (NZ)
Title: Notch pathway signaling inhibitor compound
Inventor: HIPSKIND PHILIP ARTHUR
IPC: C07K5/06
Filed: 2012-07-18
Abstract: Provided is the compound 4,4,4-trifluoro-N-[(1S)-2-[[(7S)-5-(2-hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3] benzazepin-7-yl]amino]-1-methyl-2-oxo-ethyl]butanamide. The compound is a Notch pathway signalling inhibitor. The compound may be useful for the treatment of cancer. Further disclosed is a crystalline hydrate of 4,4,4-trifluoro-N-[(1S)-2-[[(7S)-5-(2-hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3] benzazepin-7-yl]amino]-1-methyl-2-oxo-ethyl]butanamide.
Patent NZ-620434-A (NZ)
Title: Agonists of src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same
Inventor: SHIAU CHUNG-WAI
IPC: A61K31/075
Filed: 2012-08-03
Abstract: Disclosed are biarylethers compounds of formula I which have Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) agonist activity. Also disclosed are pharmaceutical compositions comprising compounds of formula I for treating cancer. Examples of a compound of formula I are: 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea 1-(4-(4-cyanophenoxy)phenyl)-3-(3,4-dimethoxybenzyl)urea 4-(3-(3-(trifluoromethyl)benzen-sulfonylamino)phenoxy)benzonitrile
Patent NZ-629282-A (NZ)
Title: 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
Inventor: HOOD JOHN
IPC: C07D231/00
Filed: 2013-05-03
Abstract: Disclosed are compounds according to Formulas (I) or (II) wherein the substituents are as defined in the specification. Also disclosed is the use of the compound for the treatment of disorders characterized by the activation of Wnt pathway signalling such as cancer, abnormal cellular proliferation, angiogenesis, Alzheimer’s disease, lung disease, osteoarthritis, idiopathic pulmonary fibrosis and neurological conditions/disorders/diseases. Examples of a compound of formula I or II are: N-Ethyl-2-(5-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide N-(S-(3-(4-(4-Methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-S-yl)pyridin-3-yl)cyclobutanecarboxamide
Patent NZ-709609-A (NZ)
Title: Benzylamine derivatives
Inventor: ALLAN CHRISTINE ELIZABETH
IPC: C07D401/06
Filed: 2014-01-08
Abstract: The present invention provides compounds of formula (I); compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein P is –C(R10)(R11)NH2 and R1 to R3, R5 to R9, A, V, W, X, Y and Z are as defined herein.
Patent NZ-710436-A (NZ)
Title: Biospecific agents for bone
Inventor: SANTIN MATTEO
IPC: A61P19/08
Filed: 2014-01-31
Abstract: A bone biospecific agent comprises a contrast material core, which is visible using Magnetic Resonance Imaging (MRI) or Computed Tomography (CT). The contrast material core is surrounded by a polymeric shell, which is functionalised with a bone- targeting peptide. In use, the peptide targets the biospecific agent to bone. The bone biospecific agent can be used in diagnostic imaging techniques, such as MRI and CT, and in imaging bone remodelling activities, detecting and treating pathological bone conditions and/or bone repair processes. The invention extends to the diagnosis and/or treatment of bone disease and bone pathologies using the biospecific agents.
Patent NZ-718145-A (NZ)
Title: A relocatable loading platform
Inventor: BLAMPIED NICHOLAS MARK
IPC: E04F11/06
Filed: 2015-04-20
Abstract: Described herein is a relocatable loading platform to assist movement of cows or cattle between a first lower elevation and a second higher elevation. The platform uses a steel frame structure with separate step panels. The platform has the advantage of being lighter weight and does not need to be permanently fixed to the ground hence can be relocated. Further, the platform may in some embodiments be modular so as to allow the platform to be transported in a semi flat form and quickly assembled on site (or dissembled and moved if necessary).
Patent NZ-720745-A (NZ)
Title: Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide
Inventor: KARKI KAPIL KUMAR
IPC: C07K5/12
Filed: 2014-12-18
Abstract: The present disclosure provides processes for the preparation of a compound of formula I: which is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.
Patent NZ-720986-A (NZ)
Title: Improved gel stability
Inventor: GANE PATRICK A C
IPC: C09K8/68
Filed: 2014-12-12
Abstract: The present invention relates to a composition having a gel strength of from 1.0 μΝ to 10.0 N, a method of preparing a composition having a gel strength of from 1.0 μΝ to 10.0 N, a method of hydraulically fracturing of a subterranean formation, preferably an oil well or gas well, a hydraulically fracturing fluid as well as the use of said composition for hydraulic fracturing of a subterranean formation. The present invention further relates to the gel and use of this gel in pharmaceutical applications, cosmetic applications, constructing applications, paper applications, paint applications, plastic applications, food applications and/or agricultural applications.
Patent NZ-730514-A (NZ)
Title: Usable cabin space of a motor vehicle
Inventor: Lukas Merz
IPC: B60N2/90
Filed: 2017-03-27
Abstract: The usable cabin space in a motor vehicle in many cases can be converted from personnel transport to materials transport, advantageously the load space should be accessible from the side. One current system allows side access but provides only bench seats with narrow back rests, which are no longer considered to provide sufficient passenger protection. An alternative system provides improved passenger protection but, only end access to the load space. The present invention provides a useful cabin space of a motor vehicle for transporting personnel and materials has a cabin frame (2) intended for a removable cabin shell and formed by longitudinal beams and transverse beams, and has a cabin interior construction with two rows of seats running opposite one another in the direction of travel and laterally above a central vehicle floor. These have seat bench panels (59) and backrests (56), which are connected to one another via a first pivot axis (79). The seat bench panels (5) together with the backrests (56), forming a loading surface, can be pivoted inwardly about a second pivot axis (65) so that the usable cabin space can be converted into a loading space accessible from the side for material transport. Seat bodies (55) each intended for a person are provided on the seat bench panels (59) and are each associated with a backrest (56) having seat belts (58) and a headrest (57). Each backrest (56) can be lowered towards the seat body (55) by means of a lowering mechanism (18) and is locked to side beams (25) detachably anchored in the cabin frame (2). This configuration improves the cabin space passenger protection and allows side loading when in the materials transport configuration. (Fig.12)
Patent NZ-735964-A (NZ)
Title: Antibodies Specific For TGF-Beta
Inventor: BEDINGER DANIEL
IPC: C07K16/18
Filed: 2012-06-01
Abstract: Disclosed is the use of an antibody that binds transforming growth factor beta (TGFβ)1, TGFβ2 and TGFβ3 comprising: (a) a heavy chain CDR1 amino acid sequence GGTFSSYA; (b) a heavy chain CDR2 amino acid sequence IIPIFGTA; (c) a heavy chain CDR3 amino acid sequence ARGLWEVRALPSVY; (d) a light chain CDR1 amino acid sequence DIGSKS; (e) a light chain CDR2 amino acid sequence set forth in EDI; and (f) a light chain CDR3 amino acid sequence QVWDRDSDQY; in the preparation of a medicament for the treatment of colorectal cancer, hepatocellular carcinoma, breast cancer, prostate cancer, pancreatic cancer, renal cancer, lung cancer, non-small cell lung carcinoma, fibrotic cancer, fibroproliferative diseases or pulmonary fibrosis.
Patent NZ-740355-A (NZ)
Title: Bollard base
Inventor: CONNELL ROBERT
IPC: E04H12/22
Filed: 2016-10-04
Abstract: A problem with known bollard base is that it is not adjustable. Various embodiments of the present disclosure provide a bollard base including a top plate, a plurality of spaced-apart anchors each integrally connected to and extending downwardly from the top plate, a plurality of adjustable leg assemblies at least partially connected to the top plate, and a tubular baffle connected to and extending downwardly from the bottom of the top plate, wherein the plurality of adjustable leg assemblies include a plurality of spaced-apart tubular legs integrally connected to and extending downwardly from the top plate, and a plurality of adjustable feet respectively partially insertable into the tubular legs. Various embodiments of the present disclosure also provide a bollard base including a top plate and a tubular baffle connected to and extending downwardly the top plate.
Patent NZ-741841-A (NZ)
Title: Antisense oligonucleotides for use in treating alzheimer’s disease
Inventor: DE VLAAM THOMAS PETRUS GERARDUS
IPC: C12N15/113
Filed: 2016-10-14
Abstract: The present invention is concerned with oligonucleotides suitable for use in treating human disease. In particular, the present invention is concerned with antisense oligoribonucleotides suitable for the treatment of Alzheimer’s disease, compositions comprising such antisense oligoribonucleotides, and methods of using such antisense oligoribonucleotides. More particularly, the present invention relates to an antisense oligoribonucleotide that is 15-34 nucleotides in length and comprises a sequence that is complementary to guguucuuugcagaa (SEQ ID NO: 32). The AON is capable of preventing exon 17 inclusion into a human APP mRNA.
Patent NZ-748864-A (NZ)
Title: Cart with removable wheel base
Inventor: CHURCHVARA JEFFREY
IPC: A47B31/00
Filed: 2015-12-21
Abstract: Moving sterile carts through different areas is problematic as contaminants can be caught during transit. Provided herein is a cart transporting items between a controlled environment (e.g., a clean room or an airlock to a clean room) and an uncontrolled environment. The cart has a main body that carries the items, and a removable and interchangeable wheel base assembly. A first wheel base assembly is located in the uncontrolled environment and a second wheel base assembly is located in the controlled environment. The user can push the cart (with the first wheel base assembly) up to the second wheel base assembly at the boundary between the controlled environment and the uncontrolled environment. The user then unlocks the main body from the first wheel base assembly, slides the main body onto the second wheel base assembly, and locks the main body to the second wheel base assembly. An autoclavable storage and transport cart can hold several wheel base assemblies.
Patent NZ-750898-A (NZ)
Title: Oil purification process
Inventor: MALM ANNIKA
IPC: C11B3/16
Filed: 2017-09-28
Abstract: The invention relates to a process for purification of oil by heat treatment in order to degrade phospholipids present in the non-purified oil.
Patent NZ-752919-A (NZ)
Title: Paver adhesive and method of laying pavers
Inventor: ELIASON WILLIAM
IPC: C04B28/04
Filed: 2016-11-08
Abstract: Conventional wisdom states that paver tiles are not made for vehicular applications in any situation and that paver tiles aren’t even designed to set in cement or mortar over existing concrete applications. One inch paver tiles may now be set over a concrete pad for use by vehicular traffic. The method and dry concrete mix may be used to overlay concrete driveways. The paver tiles may be laid over a dry concrete mix comprising a latex polymer. Portland cement, sand and a hydration control agent. After laying the paver tiles in a field over the concrete mix in the dry state, a border of paver tiles or other material may he laid in a wet concrete mix prior to hydrating the field paver tiles. The dry concrete mix cures after hydration to form a strong layer adhering the paver tiles to the concrete pad for use by vehicular traffic.
Patent PT-103587-A (PT)
Title: Chapéu exaustor deprimogéneo
Inventor: ALMEIDA JOSE PAULO PEREIRA DE
IPC: F23L17/02
Filed: 2006-10-13
Abstract: A presente patente descreve o CHAPÉU EXAUSTOR DEPRIMOGÉNEO, representado na Figura 1, o qual consegue transformar o efeito nefasto de certas direcções de ventos incidentes em chaminés e tubos de arejamento numa vantagem em termos de incremento da sua tiragem. O CHAPÉU EXAUSTOR DEPRIMOGÉNEO consiste na ligação, através de 4 alhetas semelhantes a (1), de dois semi-elipsóides de revolução de eixo vertical (2), (3), sendo que o semi-elipsóide de revolução inferior (2) tem o seu pólo virado para cima e vazado com um casquilho (4) para ligação ao topo da chaminé ou do tubo de arejamento e o semi-elipsóide de revolução superior tem o seu pólo virado para baixo (3), conseguindo-se assim encaminhar o vento de qualquer direcção para a secção contraída no topo da chaminé ou do tubo de arejamento gerando-se uma depressão que incrementa a tiragem. O dipositivo dispõe ainda de pingadeira (5) e rede contra pássaros (6)
Patent PT-104201-A (PT)
Title: Composição de revestimento para acrílico, sistema acrílico reforçado possuindo motivos decorativos e suas utilizações
Inventor: TEIXEIRA JOSE FRANCISCO DE LIM
IPC: C09D1/00
Filed: 2008-09-30
Abstract: DIVULGA-SE UMA NOVA COMPOSIÇÃO A PARTIR DA QUAL PODEM SER PRODUZIDOS REVESTIMENTOS PARA APLICAÇÃO EM MATERIAIS ACRÍLICOS, DE UM MODO PREFERIDO MATERIAIS ACRÍLICOS TRANSPARENTES, QUE PERMITEM NÃO SÓ O SEU EMBELEZAMENTO COMO A APLICAÇÃO DE MATERIAL DE REFORÇO, SUPERANDO OS PROBLEMAS DE ADERÊNCIA E FISSURAÇÃO DA TÉCNICA ANTERIOR E PERMITINDO CRIAR PEÇAS DIFERENCIADAS, FIÁVEIS E DURADOURAS. A NOVA COMPOSIÇÃO DE REVESTIMENTO TRADUZ-SE NUMA TINTA 100% REACTIVA, CATALIZADA E SEM SOLVENTES, SENDO A SUA APLICAÇÃO BASTANTE RÁPIDA E O PERÍODO DE ''CURA'' INFERIOR A 20 MINUTOS, DEPENDENDO DA TEMPERATURA AMBIENTE.
Patent PT-106258-A (PT)
Title: Roupa interior masculina com bolsa interna de colocação e transporte da globalidade do aparelho genital masculino
Inventor: BARRETO FREDERICO PINTO CAMELO DE OLIVEIRA
IPC: A41B9/02
Filed: 2012-04-17
Abstract: O PRESENTE PEDIDO DE PATENTE REFERE-SE A UMA PEÇA DE ROUPA INTERIOR MASCULINA CONTENDO, NA SUA FACE FRONTAL INTERNA INTERIOR, UMA BOLSA PARA COLOCAÇÃO E TRANSPORTE DA GLOBALIDADE DO APARELHO GENITAL MASCULINO (DORAVANTE REFERIDA APENAS COMO ¿BOLSA INTERNA¿ OU ¿BOLSA¿). A BOLSA ESTÁ COLOCADA NO INTERIOR DA PEÇA DE ROUPA, E LOCALIZADA NA ZONA FRONTAL CENTRAL (4) E (8). O EXTERIOR DA PEÇA NÃO TEM QUALQUER MARCA OU REFERÊNCIA VISÍVEL À EXISTÊNCIA DA BOLSA (1) E (2), APENAS AS NORMAIS COSTURAS DE SUPORTE À PEÇA DE ROUPA. IGUALMENTE, AS COSTAS DO INTERIOR (6) NÃO TÊM QUALQUER MARCA OU REFERÊNCIA VISÍVEL À EXISTÊNCIA DA BOLSA, APENAS AS NORMAIS COSTURAS DE SUPORTE À PEÇA DE ROUPA. A BOLSA LOCALIZA-SE NO INTERIOR FRONTAL DA PEÇA DE ROUPA (3) E (7), E É CONSTITUÍDA DE MATERIAL IGUAL À RESTANTE PEÇA DE ROUPA. A ABERTURA DA BOLSA LOCALIZA-SE NA ZONA SUPERIOR FRONTAL (4) E (8) E TEM AS RESPETIVAS COSTURAS NAS LATERAIS DA BOLSA (5). O PRESENTE PEDIDO DE PATENTE É APLICÁVEL NO FABRICO DE PEÇAS DE ROUPA INTERIOR PARA HOMENS.
Patent RU-94010362-A (RU)
Inventor: BEZZUBTSEV V V
IPC: H03K5/00
Filed: 1994-03-24
Abstract: FIELD: measurement technology. SUBSTANCE: signal transducer has operational amplifier, first diode whose anode (cathode) is connected to output of operational amplifier and cathode (anode), to operational amplifier inverting input through first resistor; noninverting input of operational amplifier is connected to input terminal; it also has capacitor one of whose poles is connected to common bus and other pole, to common point of connection of first diode and first resistor and to output terminal, second diode whose cathode (anode) is connected to operational amplifier output and anode (cathode), to operational amplifier inverting input through second resistor. EFFECT: improved measurement accuracy.
Patent RU-94024076-A (RU)
Inventor: ERMAKOV E I
IPC: C05F11/04
Filed: 1994-07-06
Abstract: FIELD: agriculture, in particular, growing of plants, land reclamation. SUBSTANCE: soil mixture contains upland peat, sand, clay, mineral fertilizers and peat acidity reducing materials. Components are used in the following ratio, g per 1 l of mixture: clay 50-60; sand 120-160; superphosphate fertilizer 1.5-2.0; complex fertilizer free of inert material 2.0-5.0; upland peat neutralized to pH value of 5.5-6.0 the balance. Method involves mixing peat with lime material and separately mineral fertilizers with clay and sand; holding obtained mixture for 7-10 days and mixing with production peat. EFFECT: increased plant productivity and simplified method.
Patent RU-94025007-A (RU)
Inventor: PETLENKO B I
IPC: B60L11/18
Filed: 1994-07-12
Abstract: FIELD: transport; vehicles set into motion by electric motor with independent supply sources. SUBSTANCE: in such vehicles, in additional to standard supply source such as storage battery, additional supply source is used which is capacitive energy accumulator. Accumulator is charged from storage battery and is connected in parallel with storage battery when accelerator pedal is pressed to stop, thus increasing traction motor current and improving dynamic performance of vehicle. Use of capacitive energy accumulator makes it possible to reduce capacity of storage battery which constitutes main portion of vehicle mass and thus decrease total mass of vehicle. EFFECT: increased service life of system owing to use of long life capacitive energy accumulator, reduced battery capacity, increased efficiency of system.
Patent RU-94028189-A (RU)
Inventor: KASIKOV A G
IPC: C22B7/00
Filed: 1994-07-27
Abstract: FIELD: nonferrous metallurgy, more particularly hydrometallurgical treatment of feedstock containing non-ferrous and noble metals. SUBSTANCE: silver-containing waste is created with neutral (pH 6-8) solution of sodium thiosulfate at concentration of 0.1-2.5 mole/l, preferably 0.25-1.0 mole/l, at 40-80 C and solid-liquid phase ratio is maintained for 10-120 minutes. On completion of the leaching process, the solution is collected by filtration, solver sulfide concentrate is precipitated from the filtrate at 20-40 C by addition sodium sulfide solution to attain redox potential of 450-550 mV and Me: S ratio of (1.2-1.8):1 wherein Me is Ag, Cu, Pb, Au. The resulting concentrate is separated which is then used as circulating solution and directed to leaching stage. The process makes it possible to attain 66-99% degree of recovery of silver into solution, selectively separate silver from the bulk of heavy non-ferrous and noble metals and recover it as 5-42% silver-containing concentrates without using toxic and aggressive reactants and employing special corrosion-resistant equipment. EFFECT: more efficient recovery process. 3 cl, 5 tbl